video

Oncology
Henar Hevia and Carolyn Sousa at ASCO 2024

ASCO 2024 - Henar Hevia and Carolyn Sousa

The future of cancer care is personalisation. New breakthroughs are increasingly highly targeted, with powerful results, but only for patients with particular genetic markers.

Oncology
Paul Burton interview with Jonah Comstock

ASCO 2024 - Paul Burton

For Amgen, ASCO 2024 was all about lung cancer, with encouraging data in both non-small cell and small cell lung cancer.

R&D
Dr Suzanne Trudel at ASCO 2024

ASCO 2024 - Suzanne Trudel

Sometimes getting a new drug to market is a relatively straight line, but sometimes it’s a winding road.

R&D
Jonah Comstock interviewing Blair McNeill at Reuters Pharma USA

Reuters Pharma USA 2024 – Blair McNeill

In today's era of cell, gene, and tissue therapies, new treatments are truly game-changing, often creating an opportunity for a healthy, normal life for people who previously had no options

Digital
Jonah Comstock interview with Mindy McGrath at Reuters Pharma USA 24

Reuters Pharma USA 2024 – Mindy McGrath

One of the most salient topics in the United States right now in pharma is market access and drug affordability, and one thing that’s driving that topic in this moment are the drug pricing